Neurostimulation device for treating mood disorders

• US 20070027499A1
• Filed: 07/29/2005
• Published: 02/01/2007
• Est. Priority Date: 07/29/2005
• Status: Abandoned Application

• Current Assignee: LivaNova USA, Inc. (LivaNova Plc)
• Original Assignee: Cyberonics, Inc
• Inventors: Brannan, Stephen, Maschino, Steven, Buras, William
• Application Number:
  US11/192,612
• Publication Number:
  US 20070027499A1
• Time in Patent Office: Days
• US Class Current: 607/45
• CPC Class Codes: A61N 1/36096 Mood disorders, e.g. depression, anxiety or panic disorder
• CPC Class Codes: A61N 1/36146 specified by the stimulation parameters

Abstract

A device and method for treating a mood and/or anxiety disorder are disclosed which provide for stimulation of certain areas of the brain to modulate neuronal activity of areas associated with symptoms of mood disorders. In certain embodiments, brain stimulation is combined with cranial nerve stimulation for enhancing symptomatic relief of the disorder. Certain embodiments also employ a sensing capability for optimizing the therapeutic treatment regimen.

Claims

1. A system for treating a mood disorder, the system comprising:

a programmable neurostimulation controller;

a first therapy delivery device adapted for coupling to said controller and for coupling to a cranial nerve of a patient suffering from a mood disorder; and

a second therapy delivery device adapted for coupling to said controller and adapted for coupling to a volume of neural tissue in an area of the patient'"'"'s brain wherein said area is selected from the group consisting of insula, subcallosal area, cingulate, thalamus, prefrontal cerebral cortex, brain stem, cerebellum, and white matter tracts leading to an aforementioned area,

wherein said controller is adapted for causing a first therapeutic signal to be applied to the cranial nerve by the first therapy delivery device, and said controller is adapted for applying a second therapeutic signal to said brain area by said second therapy delivery device, wherein said application of said first and second therapeutic signals causes modulation of electrical activity in the brain area correlatable to alleviation of a symptom of a mood disorder in a patient, when said system is used for the stated purpose.

2. The system of claim 1 wherein said first therapy delivery device is adapted for coupling to a cranial nerve chosen from the group consisting of vagus, trigeminal, hypoglossal and accessory nerves.

3. The system of claim 1 wherein said first and/or second therapy delivery device comprises an electrode and said first and/or second therapeutic signal comprises an electrical signal.

6. The system of claim 1 wherein said second therapeutic stimulation signal comprises a second acute stimulation component and a second chronic stimulation component, each of said second acute and chronic stimulation components comprising a set of electrical parameters, on/off times and duration.

7. The system of claim 6 wherein said second acute stimulation component comprises a higher level of electrical current and shorter duration than said second chronic stimulation component.

8. The system of claim 7 wherein said first and/or second electrode is adapted for delivering an electrical stimulus to said nerve or neural tissue and is also adapted for sensing neuronal activity in said nerve or neural tissue, and said controller is adapted for receiving and processing a sensed electrical signal from said first and/or second electrode, to produce an indication of whether said first and/or second therapeutic electrical signal causes modulation of neuronal activity in said brain area, wherein a predetermined neuronal activity in said brain area is correlatable to at least one symptom of a mood disorder.

9. The system of claim 1 wherein said first and/or second therapy delivery device a chemical delivery device coupled to said controller, and wherein said controller is adapted for causing said second therapeutic signal to cause a chemical agent to be released by the chemical device to the selected brain area, wherein said application of said first and second therapeutic signals causes modulation of electrical activity in the brain area correlatable to alleviation of a symptom of a mood disorder in a patient.

10. The system of claim 8 wherein the chemical agent is selected from a group consisting of inhibitory neurotransmitter agonists, excitatory neurotransmitter antagonists, agents that increase the level of an inhibitory neurotransmitter, agents that decrease the level of an excitatory neurotransmitter, and local anesthetic agents.

4. The system of 1 wherein said first therapeutic signal comprises at least a first acute stimulation component and a first chronic stimulation component, each of said first acute and chronic stimulation components comprising a set of electrical parameters, on/off times and duration.

5. The system of claim 4 wherein said first acute stimulation component comprises a higher intensity level of electrical current and shorter duration than said first chronic stimulation component.

11. A system for treating a mood disorder, the system comprising:

a programmable neurostimulation controller;

a first electrode adapted for coupling to said controller and for coupling to a cranial nerve of a patient suffering from the mood disorder; and

a second electrode adapted for coupling to said controller, adapted for coupling to a volume of neural tissue in an area of the patient'"'"'s brain, and adapted for sensing at least one biological parameter of said neural tissue that is indicative of a present state of said brain area,

wherein said controller is adapted for causing a first electrical signal to be applied to the cranial nerve by said first electrode, and said controller is adapted for receiving and processing a sensed present state from said second electrode, to produce an indication of whether said first electrical signal caused modulation of neuronal activity in said brain area, wherein a predetermined neuronal activity in said brain area is correlatable to at least one symptom of a mood disorder.

12. The system of claim 11 wherein said first electrode is adapted for coupling to a cranial nerve selected from the group consisting of vagus, trigeminal, hypoglossal, and accessory nerves.

13. The system of claim 11 wherein said at least one parameter of said neural tissue comprises electrical activity and said controller comprises a comparator adapted for comparing sensed electrical activity received from said second electrode to a predetermined reference electrical activity state, and is adapted for yielding comparison results, for determination from said comparison results whether the application of the first electrical signal to said first electrode causes a modulation of neuronal activity in the selected brain area, wherein said modulation of neuronal activity corresponds to alleviation of a symptom of said mood disorder.

14. An adaptive brain stimulation system for treating a mood disorder, the system comprising:

at least one sensor adapted for coupling to a sensing site in a patient suffering from a mood disorder and adapted for sensing at least one biological parameter at said site that is indicative of a present state of at least a first brain region or set of brain regions and a second brain region or set of brain regions of said patient;

at least one stimulating circuit adapted for coupling with at least said first brain region or set of brain regions by at least one stimulation electrode, to carry out stimulation according to a first set of stimulation parameters;

a comparator coupled with said at least one sensor, said comparator adapted for receiving data related to the present state and comparing said present state data with reference state data, such that said comparing results in a positive outcome or a negative outcome; and

at least one control circuit coupled with said at least one stimulating circuit adapted for being adjusted according to the outcome of said comparing of said present and reference states, to control said stimulation parameters.

15. The system of claim 14 wherein said at least one stimulating circuit is further adapted for coupling with a second brain region or set of brain regions by a stimulation electrode, to carry out stimulation according to a second set of stimulation parameters.

16. The system of claim 14 comprising an implantable power source coupled to an implantable stimulus generator, said stimulus generator comprising said comparator and said at least one control circuit and said first and second stimulating circuits.

17. A system for treating a mood disorder, the system comprising:

a programmable neurostimulation controller; and

a therapy delivery device adapted for coupling to said controller and adapted for coupling to a volume of neural tissue in an area of the brain of a person suffering from a mood disorder, wherein said area is chosen from the group consisting of insula, brain stem, cerebellum, and white matter tracts leading to an aforementioned area,

wherein said controller is adapted for causing a first therapeutic stimulation signal to be provided to said therapy delivery device to thereby cause neuronal activity of an area of the person'"'"'s brain to be modified and thereby alleviate a symptom of the mood disorder.

18. The system of claim 17 wherein said first therapeutic stimulation signal comprises an acute stimulation component and a chronic stimulation component.

19. The method of claim 18 wherein said acute stimulation component comprises a higher level of stimulation and shorter duration than said chronic stimulation component.

20. The method of claim 18 wherein said acute stimulation component comprises a duration of one to six months.

21. The system of claim 17 wherein said therapy delivery device comprises a chemical stimulation device comprising:

a pump coupled to said controller;

a catheter having a proximal end in fluid communication with a pump and a discharge portion for infusing a chemical agent, and

wherein said first therapeutic stimulation signal comprises a predetermined pumping signal, and

wherein said chemical stimulation device is adapted for causing said chemical agent to be released from said discharge portion and contact said predetermined area, whereby the neuronal activity of said predetermined area is caused to be modified.